114 related articles for article (PubMed ID: 6168727)
1. Comparison of serum beta 2-microglobulin and carcinoembryonic antigen (CEA) in the follow-up of breast cancer patients.
Staab HJ; Ahlemann LM; Anderer FA; Hiesche K; Rodatz W
J Clin Chem Clin Biochem; 1981 Jun; 19(6):339-45. PubMed ID: 6168727
[TBL] [Abstract][Full Text] [Related]
2. Is serum beta 2-microglobulin a tumor marker in gastrointestinal cancer?
Staab HJ; Anderer FA; Hiesche K; Wehrle E; Rodatz W
Clin Chim Acta; 1980 Oct; 106(3):309-17. PubMed ID: 6158388
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the variations in the levels of beta2-microglobulin and carcino-embryonic antigen in the breast cancer and malignant melanoma (author's transl)].
Grenier J; Serrou B; Suquet P; Pujol H
Pathol Biol (Paris); 1978 Sep; 26(6):371-2. PubMed ID: 83589
[TBL] [Abstract][Full Text] [Related]
4. [Carcino-embryonic antigen and beta 2 microglobulin in malignant bone diseases. 61 cases (author's transl)].
Trèves R; Clément A; Desproges-Gotteron R; Olivier JP; Beck C
Nouv Presse Med; 1982 Jan; 11(1):21-4. PubMed ID: 6173840
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mammary serum antigen (MSA) with beta 2-microglobulin (beta 2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer.
Tjandra JJ; McLaughlin PJ; Russell IS; Collins JP; McKenzie IF
Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1633-40. PubMed ID: 3061824
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
[TBL] [Abstract][Full Text] [Related]
7. Serum beta 2--microglobulin and carcinoembryonic antigen in patients with gastric disorders.
Satake K; Kitamura T; Ishikawa T; Mukai R; Yoshimoto T; Chung YS; Umeyama K
J Surg Oncol; 1981; 17(3):225-33. PubMed ID: 6166812
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen and beta 2-microglobulin as serum tumor markers in women with genital cancer.
Khoo SK; Daunter B; Mackay E
Int J Gynaecol Obstet; 1979; 16(5):388-93. PubMed ID: 86469
[TBL] [Abstract][Full Text] [Related]
9. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of the assay of beta 2 microglobulin during the monitoring of surgically-treated colorectal cancers. Comparison with carcinoembryonic antigen].
Triboulet JP; Dessaint JP; Lagache G
Gastroenterol Clin Biol; 1983 Oct; 7(10):808-11. PubMed ID: 6354822
[TBL] [Abstract][Full Text] [Related]
11. Serial tests of carcinoembryonic antigen in patients with breast cancer.
Lee YT
Am J Clin Oncol; 1983 Jun; 6(3):287-93. PubMed ID: 6846246
[TBL] [Abstract][Full Text] [Related]
12. [What value should be given to assays of serum ferritin in breast cancers? Correlation with various biological parameters].
Dalifard I; Daver A; Cellier P; Larra F
Sem Hop; 1984 Jan; 60(3):157-62. PubMed ID: 6320439
[TBL] [Abstract][Full Text] [Related]
13. [beta2-Microglobulin in cancer patients (author's transl)].
Daver A; Chassevent A; Bouali AB; Bertrand AF; Deroche C; Cellier P; Tuchais C; Souaille C; Maillart P; Bertrand G; Minier JF; Larra F; Agerup B
Pathol Biol (Paris); 1978 Sep; 26(6):335-40. PubMed ID: 83577
[TBL] [Abstract][Full Text] [Related]
14. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of serum levels of beta2-microglobulin and carcino-embryonic antigen in the follow-up of lung cancer (author's transl)].
Ardiet C; Gonthier R; Pasquet P; Lahneche B
Pathol Biol (Paris); 1978 Sep; 26(6):355-7. PubMed ID: 83584
[TBL] [Abstract][Full Text] [Related]
16. Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients.
Molina R; Zanón G; Filella X; Moreno F; Jo J; Daniels M; Latre ML; Giménez N; Pahisa J; Velasco M
Breast Cancer Res Treat; 1995; 36(1):41-8. PubMed ID: 7579505
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous plasma determination of CEA, HCG-beta and beta-2-microglobulin in patients with nontrophoblastic tumors.
Ruibal A; Gultresa J
Tumori; 1980 Jun; 66(3):305-9. PubMed ID: 6160667
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
19. [beta2-Microglobulin and carcino-embryonic antigen in bronchogenic carcinoma (author's transl)].
Bisset JP; Poirier R; Roux F; Sauvan R; Kleisbauer JP
Pathol Biol (Paris); 1978 Sep; 26(6):353-4. PubMed ID: 83583
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of biochemical analysis of pleural effusions. Carcinoembryonic antigen and beta 2 microglobulin.
Vladutiu AO; Adler RH; Brason FW
Am J Clin Pathol; 1979 Feb; 71(2):210-4. PubMed ID: 85412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
